Financials data is unavailable for this security.
View more
Year on year Akums Drugs and Pharmaceuticals Ltd had net income fall from a gain of 948.55m to a loss of 40.35m despite a 14.32% increase in revenues from 36.55bn to 41.78bn.
| Gross margin | -- |
|---|---|
| Net profit margin | -- |
| Operating margin | -- |
| Return on assets | -- |
|---|---|
| Return on equity | -- |
| Return on investment | -- |
More ▼
Cash flow in INRView more
In 2024, Akums Drugs and Pharmaceuticals Ltd increased its cash reserves by 115.18%, or 594.42m. The company earned 4.98bn from its operations for a Cash Flow Margin of 11.92%. In addition the company used 3.30bn on investing activities and also paid 1.08bn in financing cash flows.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | -- |
|---|---|
| Tangible book value per share | -- |
More ▼
Balance sheet in INRView more
| Current ratio | -- |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | -- |
More ▼
Growth rates in INR
Year on year, growth in earnings per share excluding extraordinary items dropped -104.25%.
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -- |
